Home > Insider Trading > Biogen Inc.

Biogen Inc. (BIIB)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
171 - 180
Next >>

AbbVie, Biogen, Gilead: Smart Money Got Burned Betting on Biotech in Q3

When it rains, it pours, and for big pharma, it certainly poured in the third quarter. With the third quarter over, let's take a closer look at the fundamentals of hedge fund hotels Pfizer Inc.

Keep Reading →

October 20th, 2015 - Hedge Funds News

Elite Investors Disagree With Saudi Prince On Twitter, Like This Trending Biotech

Shares of Twitter Inc (NYSE:TWTR) and Biogen Inc (NASDAQ:BIIB) are up by 4% and 2.4% respectively in afternoon trading, as investors become more optimistic about the two companies' prospects.

Keep Reading →

October 7th, 2015 - Market Movers News

Insiders Were Buying Up Shares Of Biogen Inc (BIIB) And These Other Companies Yesterday

Among all the insider buying and selling activity yesterday, we identified three companies which had a large volume of insider purchases in terms of monetary value, either by one or more insiders of the...

Keep Reading →

July 28th, 2015 - Hedge Funds Insider Trading News

Biogen Inc (BIIB) Faces Biggest Intraday Drop in 7 Years After Missing Earnings Expectations

The shares of Biogen Inc (NASDAQ:BIIB) were down by 21.52% after missing analysts’ revenue expectations for the quarter and slashing its revenue guidance for the full fiscal year.

Keep Reading →

July 24th, 2015 - Hedge Funds Market Movers News

Billionaire Stanley Druckenmiller’s Top Value Picks Include Illumina, Inc. (ILMN), Biogen Inc (BIIB), LyondellBasell Industries NV (LYB)

Billionaire Stanley Druckenmiller, a PhD from the University of Michigan, is one of the titans of the hedge fund industry.

Keep Reading →

May 19th, 2015 - Hedge Funds News

Krishen Sud's Sivik Global Loves These Healthcare Stocks

Krishen Sud’s Sivik Global Healthcare has filed its latest 13F with the SEC, disclosing the holdings in its equity portfolio as of March 31.

Keep Reading →

April 24th, 2015 - Hedge Funds News

Billionaire Stanley Druckenmiller Squashed the Market in Q1 With These Top Picks

Stanley Druckenmiller’s Duquesne Capital easily outpaced the timid Q1 market, in which the S&P 500 returned just 0.9%.

Keep Reading →

April 22nd, 2015 - Hedge Funds News

Receptos Inc (RCPT), Centene Corp (CNC): Paul Sinclair Flying High With New Fund's Top Healthcare Picks

Paul Sinclair's newly established healthcare-focused fund, Blue Jay Capital Management posted an impressive 12% return during the first quarter, significantly outperforming the S&P 500 ETF (SPY) that ...

Keep Reading →

April 14th, 2015 - Hedge Funds News

Healthcare Hedge Fund Orbimed's Top Picks and New Move

According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay's Orbimed Advisors has slashed its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT) by about...

Keep Reading →

March 26th, 2015 - Hedge Funds News

Biogen Idec Inc (BIIB), Celgene Corporation (CELG), bluebird bio Inc (BLUE): Stanley Druckenmiller Bets on Biotech and Wins

In the last couple of years, biotechnology industry has been a hot topic and investors have been watching closely as the industry gained on average 40% in the last three years (the second-highest return...

Keep Reading →

March 23rd, 2015 - Hedge Funds News